A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant

NCT06932562 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1000

Enrollment

NETWORK

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Linvoseltamab
DRUG: Daratumumab
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

European Myeloma Network B.V.

Collaborators

[object Object]